Zealand Pharma achieved notable organizational growth in 2024 with a 30% increase in the number of employees compared to 2023 ...
A transformational year with significant clinical advancement across differentiated obesity pipeline, while building the ...
Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023Full year revenues increased 473% to $290.5 million versus ...
At this time, I would like to welcome everyone to the Karyopharm Therapeutics fourth quarter and full year 2024 financial results conference call. There will be a question-and-answer session to follow ...
Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ETCompany ParticipantsCecilia Furlong - Director of ...
GU ASCO annual meeting featured a session on emerging trends in germ cell tumors and a presentation by Dr. Darren Feldman discussing the landscape of new trials and targets in refractory germ cell ...
Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023 Full year revenues increased 473% to $290.5 million versus 2023 CFF TDN granted full sanctioning of KB407 Phase ...
Pavan Kanchi's journey says it all about an integrated approach-a thorough technical expertise, cross-functional acumen, and a relentless passion for ongoing learning all combined towards the ...
TORONTO, ON / ACCESS Newswire / February 18, 2025 / Galway Metals Inc. (the "Company" or "Galway") is pleased to report metallurgical results from 4 PQ diamond drill holes from the Southwest, ...
The ongoing evolution of real-world evidence from a novel concept to a cornerstone of modern medical research signifies its ...
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results